We’re looking forward to connecting with the clinical community at the #ASH24 Annual Meeting to discuss the latest advances in the treatment of complex blood cancers and how we’re building on our ambition to get #InFrontofCancer.

At J&J, we remain focused on transforming multiple myeloma care. At this year’s #ASH24 Annual Meeting, we’re sharing our vision for the future where multiple myeloma is redefined as curable, and those diagnosed can live as people, not patients. #InFrontofCancer

We have partnered with leading voices in prostate cancer care: Professor Alison Birtle, Dr Erik Briers and Carl Guenther, expert patient advocate members of @Europa_Uomo, to explore the power of shared decision-making for people living with prostate cancer brnw.ch/21wPhHj

Shared decision making is an important part of the care journey for people with lung cancer. Yet, recent survey findings from Lung Cancer Europe suggest that this isn’t a reality - only 49.3% of people are highly involved in the process.

Real-world data is key to deepen our understanding of multiple myeloma and optimise patient outcomes. Read how HONEUR is demonstrating the value of innovative therapies for patients in Europe: brnw.ch/21wPmMT #ASH24 #InFrontofCancer

Smouldering multiple myeloma represents a heterogenous disease that has a high risk of progression to active myeloma.¹ Raising awareness of this precursor disease can help identify and manage the disease sooner, potentially improving long-term outcomes. #ASH24 #InFrontofCancer

Proactive disease monitoring and care is highly recommended for people living with #InflammatoryBowelDisease (IBD). For @EFCCA’s Chairman, Salvo Leone, this can support better health and quality of life outcomes for IBD patients in the long-term.

Can the skin forget #psoriasis? Even after psoriasis lesions heal, skin memory can trigger flare-ups, causing emotional distress and impacting quality of life.

Did you know there is a strong correlation between stress and the recurrence of psoriasis? For patients like Hanna, this cycle of psoriasis remission and recurrence can lead to continuous feelings of anxiety and stress. #Psoriasis

Collaboration with different stakeholders, from pharmaceutical companies to healthcare providers and patients can lead to better patient outcomes for people living with #InflammatoryBowelDisease. Learn more from @EFCCA below.

Can we help patients and their skin forget about #psoriasis? For our Strategy & Operations Director Dermatology & Rheumatology, Loïc Galmard, this is all about tackling disease beyond the symptoms. #Psoriasis

World Cancer Day is an important reminder of the significant unmet medical needs that remain for people living with cancer – and every unique experience matters. Learn more about our aim to be in front of cancer: brnw.ch/21wQscN #WorldCancerDay #UnitedByUnique

Cancer patients can't afford to wait, yet barriers to treatment persist. Martin Price, VP of Health Economics, Market Access & Reimbursement, joined EMJ to explore how we can improve access to innovative cancer therapies. Listen here brnw.ch/21wQtWc #WorldCancerDay

We’re excited for #EAU2025, where we’ll share how we’re advancing our ambition to get #InFrontOfCancer. This starts with centring the patient voice at the heart of treatment and care and promoting true shared decision-making. Learn more: brnw.ch/21wRu1z

Lung cancer remains a major health challenge, but innovation is changing the future. At J&J, we’re advancing more personalised, targeted solutions for those who need them most. Join us at #ELCC25 to discover how we’re building on our ambition to get in front of cancer.

The 33rd European Psychiatric Association Congress begins in Madrid. We're proud to drive real-world mental health solutions through innovation, collaboration, and precision science – easing the burden of neuropsychiatric disorders. Together, we can drive change. #EPA2025

There is limited research on inflammatory bowel disease in paediatric patients. This is often due to factors like misdiagnosis and clinical trial age restrictions. #InflammatoryBowelDisease

We are onsite at #AUA25, meeting with peers from across the global bladder cancer community to reflect on crucial innovations to improve patient outcomes. Hear from the experts on how we can drive the next generation of bladder cancer treatment: brnw.ch/21wSi7I

At European Psychiatric Association Congress 2025, attendees put themselves in the shoes of people living with severe depression and their caregivers by taking a journey through “the maze.” Hear their reactions to this immersive experience. #BreakingDepression

We’re excited to be in Helsinki, meeting with colleagues and partners from around the world at the European Academy of Neurology congress. #EAN2025 provides an opportunity to gather together and work towards better outcomes for people living with autoantibody diseases like myasthenia gravis.